CYTEK BIOSCIENCES, INC.
Ownership & governance
Executives 5Directors 7Avg age 64Avg tenure 6.2y
WJ
Wen Bin Jiang
Chief Executive Officer
Age 62Since 2014-11-30Profile →
+11
Executives5
Board of directors7
WJ
Wen Bin Jiang→
Chairman
Age 62Since 2014-11-30
MY
Ming Yan→
Director/Board Member
Age 63Since 2014-12-31
VI
Vera Imper→
Director/Board Member
Age 64Since 2021-12-30
DN
Deborah Neff→
Director/Board Member
Age 73Since 2022-05-31
MH
Michael Holder→
Director/Board Member
Age 63Since 2024-06-04
RC
Richard Chin→
Director/Board Member
Age 59Since 2025-05-31
GM
Glenn Muir→
Director/Board Member
Age 67Since 2026-06-09
Shareholders5
| Name | Stake | Shares |
|---|---|---|
| BlackRock Advisors LLC | 12.59 % | 16,258,567 |
| Millennium Management LLC | 6.096 % | 7,872,900 |
| Topline Capital Management LLC | 5.47 % | 7,064,481 |
| HHLR Advisors Ltd. (Cayman Islands) | 5.155 % | 6,657,030 |
| Millennium Management LLC | 4.872 % | 6,291,798 |
Catalog · 2026-07-09
Registry officers12
| Name | Role | Since | Shares |
|---|---|---|---|
| Mark Edinger | Chief Tech/Sci/R&D Officer | 2020-12-31 | - |
| Ming Yan | Chief Tech/Sci/R&D Officer | 2014-12-31 | - |
| Wen Bin Jiang | Chairman | 2014-11-30 | - |
| Wen Bin Jiang | Chief Executive Officer | 2014-11-30 | - |
| William McCombe | Director of Finance/CFO | 2024-03-18 | - |
| Deborah Neff | Director/Board Member | 2022-05-31 | - |
| Glenn Muir | Director/Board Member | 2026-06-09 | - |
| Michael Holder | Director/Board Member | 2024-06-04 | - |
Registry · as of 2026-07-09
Institutional (13F)
Loading Form 13F holders…
Fund membership
Loading fund baskets…
Street consensus
Consensus buyMean target 5.56Range 4.75–7.5Analysts 4
4.75Mean 5.567.5
- Strong buy 1
- Buy 1
- Hold 2
Broker actions36
| Firm | Action | To | Target | Date |
|---|---|---|---|---|
| Stephens & Co. | Maintained | Overweight | 4.75 | 2026-05-13 |
| Morgan Stanley | Maintained | Equal-Weight | 5.5 | 2026-05-12 |
| TD Cowen | Maintained | Buy | 5 | 2026-01-08 |
| Piper Sandler | Maintained | Overweight | 7.5 | 2025-11-11 |
| Morgan Stanley | Maintained | Equal-Weight | 7 | 2025-05-28 |
| Goldman Sachs | Maintained | Sell | 3 | 2025-05-12 |
| Stephens & Co. | Reiterated | Overweight | 6 | 2025-03-19 |
| Piper Sandler | Maintained | Overweight | 8 | 2025-03-04 |
| Piper Sandler | Maintained | Overweight | 8.5 | 2024-11-11 |
| Piper Sandler | Maintained | Overweight | 8 | 2024-08-13 |
| Piper Sandler | Maintained | Overweight | 8.5 | 2024-05-13 |
| Piper Sandler | Maintained | Overweight | 10 | 2024-03-06 |
Firm rows and rating mix from Yahoo Finance; mean target is Yahoo’s aggregate until OpenFilings derives consensus from broker rows.